Abstract

Visceral leishmaniasis (VL) is a vector-borne infectious disease that can be potentially fatal if left untreated. In Brazil, it is caused by Leishmania infantum parasites. Blood transcriptomics allows us to assess the molecular mechanisms involved in the immunopathological processes of several clinical conditions, namely, parasitic diseases. Here, we performed mRNA sequencing of peripheral blood from patients with visceral leishmaniasis during the active phase of the disease and six months after successful treatment, when the patients were considered clinically cured. To strengthen the study, the RNA-seq data analysis included two other non-diseased groups composed of healthy uninfected volunteers and asymptomatic individuals. We identified thousands of differentially expressed genes between VL patients and non-diseased groups. Overall, pathway analysis corroborated the importance of signaling involving interferons, chemokines, Toll-like receptors and the neutrophil response. Cellular deconvolution of gene expression profiles was able to discriminate cellular subtypes, highlighting the contribution of plasma cells and NK cells in the course of the disease. Beyond the biological processes involved in the immunopathology of VL revealed by the expression of protein coding genes (PCGs), we observed a significant participation of long noncoding RNAs (lncRNAs) in our blood transcriptome dataset. Genome-wide analysis of lncRNAs expression in VL has never been performed. lncRNAs have been considered key regulators of disease progression, mainly in cancers; however, their pattern regulation may also help to understand the complexity and heterogeneity of host immune responses elicited by L. infantum infections in humans. Among our findings, we identified lncRNAs such as IL21-AS1, MIR4435-2HG and LINC01501 and coexpressed lncRNA/mRNA pairs such as CA3-AS1/CA1, GASAL1/IFNG and LINC01127/IL1R1-IL1R2. Thus, for the first time, we present an integrated analysis of PCGs and lncRNAs by exploring the lncRNA–mRNA coexpression profile of VL to provide insights into the regulatory gene network involved in the development of this inflammatory and infectious disease.

Highlights

  • Leishmania protozoans cause a group of diseases known as leishmaniases

  • We provided an expression profile of Long noncoding RNA (lncRNA) induced in visceral leishmaniasis (VL) during L. infantum infection associated with coexpressed protein coding genes, uncovering important insights into the transcriptional response of this parasitic infectious disease

  • A multidimensional scaling (MDS) plot of the gene dataset was built to visualize the similarity across the 29 individuals represented by 40 samples

Read more

Summary

Introduction

The diseases are characterized by a wide range of clinical manifestations depending on the infecting Leishmania species, which are classified as cutaneous, mucocutaneous or visceral forms. This dixenous and dimorphic parasite is transmitted to humans through bites from infected sand flies [1]. Human cases in Brazil account for approximately 95% of reported VL cases in the Americas, with a mortality rate of 7.2% [3]. It is classified as a zoonotic disease with dogs and wild animals as reservoirs. As observed for other infectious diseases, most infected people do not become sick or even develop any symptoms, likely due to the diverse factors influencing the complexity of the host/parasite interface

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call